Answers are grounded in this paper and cite their sources.
Cohort analysis assesses HPV’s long-term survival impact in head and neck cancer, suggesting implications for treatment strategies.
e18129 Background: Human papillomavirus (HPV) infection is a prominent risk factor for head and neck cancers (HNC) of the lip, oral cavity, and pharynx, often linked to improved prognosis. However, its long-term effects on survival and systemic comorbidities, particularly modulated by nicotine dependence, warrant further elucidation to inform precision oncology strategies. Methods: We investigated the long-term influence of HPV status on all-cause mortality and selected comorbidities in HNC patients, with stratification by nicotine dependence. This retrospective cohort study utilized deidentified electronic medical records from the TriNetX federated network. Adult patients (≥18 years) diagnosed with HNC were categorized into HPV-positive (HPV+) and HPV-negative (HPV-) cohorts, analyzed overall and within a nicotine-dependent subgroup. Propensity score matching (1:1) balanced cohorts on age, sex, race, ethnicity, body mass index, and ECOG performance status. Results: The overall matched cohort included 9,187 HPV- and 9,187 HPV+ patients. HPV+ status was associated with comparable mortality risk (risk difference (RD), -0.009 [95% CI, -0.021 to 0.003]) but enhanced survival (median survival, 6017 vs 5689 days; end-window probability, 46.67% vs 38.66%; log-rank P < .001; HR, 0.84 [CI, 0.79-0.89]). HPV+ patients showed increased volume depletion (RD, -0.025 [CI, -0.041 to -0.009]; HR, 0.81 [CI, 0.76-0.87]) and decreased lipid metabolism disorders (RD, 0.021 [CI, 0.006-0.036]), with favorable HRs for kidney disease (0.88 [CI, 0.80-0.95]) and ischemic heart disease (0.87 [CI, 0.79-0.94]). The nicotine-dependent matched cohort comprised 5,628 patients per group. Mortality was similar (RD, 0.008 [CI, -0.008 to 0.025]; HR, 0.95 [CI, 0.88-1.02]). HPV+ was linked to elevated malaise/fatigue risk (RD, -0.025 [95% CI, -0.044 to -0.006]; HR, 0.83 [CI, 0.76-0.91]), without significant differences in other comorbidities. Conclusions: HPV positivity in HNC is associated with superior long-term survival overall, but this benefit is attenuated in nicotine-dependent patients, underscoring the synergistic adverse effects of smoking and HPV. Elevated risks of electrolyte imbalances and fatigue in HPV+ subgroups highlight the need for tailored monitoring and supportive care to mitigate these complications.
No takes yet. Share an insight, caveat, or question.
Sankaran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: